182 related articles for article (PubMed ID: 32072678)
1. The combination of artesunate and carboplatin exerts a synergistic anti-tumour effect on non-small cell lung cancer.
Wang Z; Wang Q; He T; Li W; Liu Y; Fan Y; Wang Y; Wang Q; Chen J
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1083-1091. PubMed ID: 32072678
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxicity of ampelopsin sodium and carboplatin in human non-small cell lung cancer cell line SPC-A1 by G
Lu L; Yang LN; Wang XX; Song CL; Qin H; Wu YJ
Chin J Integr Med; 2017 Feb; 23(2):125-131. PubMed ID: 27299463
[TBL] [Abstract][Full Text] [Related]
3. Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway.
Li W; Ma G; Deng Y; Wu Q; Wang Z; Zhou Q
Gene; 2021 Jan; 766():145134. PubMed ID: 32898605
[TBL] [Abstract][Full Text] [Related]
4. Dithiolation indolizine exerts viability suppression effects on A549 cells via triggering intrinsic apoptotic pathways and inducing G2/M phase arrest.
Li G; Wu X; Sun P; Zhang Z; Shao E; Mao J; Cao H; Huang H
Biomed Pharmacother; 2021 Jan; 133():110961. PubMed ID: 33190035
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer.
Wang JN; Zhang ZR; Che Y; Yuan ZY; Lu ZL; Li Y; Li N; Wan J; Sun HD; Sun N; Puno PT; He J
Cancer Biol Ther; 2018 Jul; 19(7):609-621. PubMed ID: 29565730
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells.
Tsai AC; Pai HC; Wang CY; Liou JP; Teng CM; Wang JC; Pan SL
Br J Pharmacol; 2014 Jan; 171(1):122-33. PubMed ID: 24116948
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
Li H; Zhu X; Zhang Y; Xiang J; Chen H
J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237
[TBL] [Abstract][Full Text] [Related]
8. Actinomycin V Suppresses Human Non-Small-Cell Lung Carcinoma A549 Cells by Inducing G2/M Phase Arrest and Apoptosis via the p53-Dependent Pathway.
Lin SQ; Jia FJ; Zhang CY; Liu FY; Ma JH; Han Z; Xie WD; Li X
Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31601054
[TBL] [Abstract][Full Text] [Related]
9. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma.
Feng F; Wang B; Sun X; Zhu Y; Tang H; Nan G; Wang L; Wu B; Huhe M; Liu S; Diao T; Hou R; Zhang Y; Zhang Z
Cancer Biol Ther; 2017 Jan; 18(1):51-62. PubMed ID: 28055291
[TBL] [Abstract][Full Text] [Related]
10. Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo.
Zhang C; Zhai S; Li X; Zhang Q; Wu L; Liu Y; Jiang C; Zhou H; Li F; Zhang S; Su G; Zhang B; Yan B
Cell Death Dis; 2014 Mar; 5(3):e1138. PubMed ID: 24651441
[TBL] [Abstract][Full Text] [Related]
11. Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells.
Xu B; Tao ZZ
Oncol Res; 2014; 22(4):213-217. PubMed ID: 26351210
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
13. Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism.
Hu P; Ni C; Teng P
Bioengineered; 2022 Mar; 13(3):6590-6599. PubMed ID: 35361045
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.
Tolis C; Peters GJ; Ferreira CG; Pinedo HM; Giaccone G
Eur J Cancer; 1999 May; 35(5):796-807. PubMed ID: 10505042
[TBL] [Abstract][Full Text] [Related]
16. Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines.
Edelman MJ; Quam H; Mullins B
Cancer Chemother Pharmacol; 2001 Aug; 48(2):141-4. PubMed ID: 11561780
[TBL] [Abstract][Full Text] [Related]
17.
Lin MX; Lin SH; Lin CC; Yang CC; Yuan SY
Anticancer Res; 2018 Jun; 38(6):3435-3445. PubMed ID: 29848694
[TBL] [Abstract][Full Text] [Related]
18. Induction of G2/M Cell Cycle Arrest via p38/p21
Pai JT; Hsu MW; Leu YL; Chang KT; Weng MS
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500594
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
Hatami E; Nagesh PKB; Jaggi M; Chauhan SC; Yallapu MM
Eur J Pharmacol; 2020 Dec; 888():173486. PubMed ID: 32805254
[TBL] [Abstract][Full Text] [Related]
20. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
